| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.032 | 8.181 | 6.060 | 18.592 | 38.926 | 40.666 | 30.359 | 23.284 | 19.510 | 21.028 |
| Total Income - EUR | 14.708 | 8.549 | 6.190 | 18.895 | 39.085 | 40.769 | 30.593 | 23.324 | 19.905 | 21.402 |
| Total Expenses - EUR | 16.353 | 13.799 | 8.932 | 15.731 | 29.876 | 35.348 | 29.990 | 22.126 | 32.848 | 24.952 |
| Gross Profit/Loss - EUR | -1.645 | -5.250 | -2.742 | 3.163 | 9.210 | 5.421 | 603 | 1.198 | -12.944 | -3.551 |
| Net Profit/Loss - EUR | -2.074 | -5.497 | -2.882 | 2.857 | 8.820 | 5.049 | 298 | 965 | -13.139 | -3.621 |
| Employees | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermapil Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.464 | 4.504 | 5.293 | 10.690 | 25.830 | 30.225 | 25.227 | 35.238 | 43.639 | 39.665 |
| Inventories | 3.323 | 1.074 | 1.855 | 5.393 | 7.196 | 8.030 | 12.841 | 14.136 | 14.646 | 14.564 |
| Receivables | 3.079 | 3.059 | 2.918 | 5.204 | 13.391 | 10.335 | 8.193 | 14.033 | 14.093 | 14.491 |
| Cash | 63 | 371 | 520 | 92 | 5.243 | 11.860 | 4.193 | 7.069 | 14.900 | 10.610 |
| Shareholders Funds | -8.934 | -14.340 | -16.979 | -13.810 | -4.723 | 416 | 704 | 1.672 | -11.472 | -15.029 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 15.464 | 18.892 | 22.330 | 24.567 | 30.561 | 29.817 | 24.523 | 33.652 | 55.310 | 54.916 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Dermapil Srl